- Home
- ANL vs JMM Comparison
ANL vs JMM Comparison
Compare ANL & JMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | ANL | JMM |
|---|---|---|
| Founded | 2004 | 1988 |
| Country | Cayman Islands | United States |
| Employees | N/A | N/A |
| Industry | | Trusts Except Educational Religious and Charitable |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.0M | 58.1M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | ANL | JMM |
|---|---|---|
| Price | $1.35 | $6.08 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 28.5K | 16.1K |
| Earning Date | 04-20-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 5.44% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.88 | $5.29 |
| 52 Week High | $2.99 | $6.10 |
Technical Indicators
Market Signals| Indicator | ANL | JMM |
|---|---|---|
| Relative Strength Index (RSI) | 51.04 | 38.81 |
| Support Level | $0.88 | $6.06 |
| Resistance Level | $1.59 | $6.15 |
| Average True Range (ATR) | 0.18 | 0.03 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 70.48 | 7.14 |
Price Performance
Historical ComparisonAbout ANL Adlai Nortye Ltd.
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.
About JMM Nuveen Multi-Market Income Fund (MA)
Nuveen Multi-Market Income Fund is a United States-based closed-end management investment company. The investment objective of the company is to provide high monthly income consistent with prudent risk to capital. The fund predominantly invests in debt securities, including, but not limited to, residential and commercial mortgage-backed securities, asset-backed securities, corporate debt obligations, convertible debt securities, U.S. government securities, and other such fixed income instruments. It may also invest in preferred stocks.